Molecular Imaging: Page 104

Lantheus touts ASCO GU talks with PSMA agent

By AuntMinnie.com staff writers

Lantheus Holdings, parent company of Lantheus Medical Imaging, along with its subsidiary Progenics Pharmaceuticals, announced their prostate-specific membrane antigen (PSMA) product candidates will be featured in three presentations at the upcoming 2021 American Society for Clinical Oncology Genitourinary (ASCO GU) virtual meeting.

February 4, 2021

Nano-MRI outduels PSMA-PET/CT for prostate cancer

By Wayne Forrest

Clinicians looking to accurately classify suspicious lymph nodes in prostate cancer patients could have another effective noninvasive option with a unique contrast-enhanced MR imaging technique, according to a study published online January 30 in the Journal of Nuclear Medicine.

February 4, 2021

Aikido invests in prostate radiopharma firm

By AuntMinnie.com staff writers

Aikido Pharma has made an investment in Convergent Therapeutics, a company developing a radiopharmaceutical for treating prostate cancer. Aikido made the investment in the form of a $2 million convertible promissory note purchase agreement.

February 1, 2021

SNMMI to hold 2021 annual meeting virtually

By AuntMinnie.com staff writers

For the second year in a row, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) will be holding its annual conference as a virtual event, due to concerns about the ongoing COVID-19 pandemic.

January 31, 2021

Invicro touts research, launches TauIQ software

By AuntMinnie.com staff writers

Konica Minolta subsidiary Invicro is directing attention to new research results from its TauIQ software for quantitative analysis of tau PET biomarker data in Alzheimer's disease clinical trials. The company has also launched the software.

January 31, 2021

How higher radiation stacks up when treating lung cancer

By Rebekah Moan

Two studies presented at the International Association for the Study of Lung Cancer world conference look at the use of higher radiation boost doses for lung cancer.

January 31, 2021

Spectrum Dynamics claims win in GE lawsuit

By AuntMinnie.com staff writers

Gamma camera developer Spectrum Dynamics is claiming a procedural victory in its lawsuit against GE Healthcare regarding digital SPECT technology.

January 28, 2021

Eckert & Ziegler breaks ground on U.S. facility

By AuntMinnie.com staff writers

Isotope technology firm Eckert & Ziegler has started building its previously announced production site to manufacture radiopharmaceuticals in Wilmington, MA.

January 28, 2021

FDG-PET/CT shows COVID-19 vaccine uptake

By AuntMinnie.com staff writers

The COVID-19 vaccine shows uptake on FDG-PET/CT, and radiologists should be careful not to confuse it with recurrent disease, according to an image review published January 28 in Radiology.

January 27, 2021

Detectnet PET radiotracer gets permanent HCPCS code

By AuntMinnie.com staff writers

Biotechnology firm RadioMedix and nuclear medicine company Curium said that the U.S. Centers for Medicare and Medicaid Services has provided a permanent Healthcare Common Procedure Coding System (HCPCS) code for their Detectnet PET diagnostic radiopharmaceutical copper-64 DOTATATE.

January 25, 2021

Fuzionaire, NMP seek new PET radiopharmaceuticals

By AuntMinnie.com staff writers

Fuzionaire Radioisotope Technologies (FRIT) and radiopharmaceutical firm Nihon Medi-Physics (NMP) are teaming up in a bid to create a new class of PET radiopharmaceuticals.

January 25, 2021

Study suggests extending Cu-64 tracer window to 3 hours

By Rebekah Moan

For patients with neuroendocrine neoplasms, the imaging time window of copper-64 (Cu-64) DOTATATE PET/CT can be extended from one hour to three hours after injection, according to new research.

January 24, 2021

Previous Page

Page 104 of 614

Next Page